A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants
Clinical trial NCT05651152 · COMPLETED
Trial details
- NCT number
- NCT05651152
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2023-11-15
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.